bexarotene and uab 30
bexarotene has been researched along with uab 30 in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boerma, LJ; Chalmers, MJ; Cox, BD; Griffin, PR; Lobo-Ruppert, S; Muccio, DD; Qui, C; Renfrow, MB; Smith, CD; Xia, G | 1 |
| Atigadda, VR; Boerma, LJ; Brouillette, WJ; Christov, K; Desphande, A; Grubbs, CJ; Lobo-Ruppert, S; Moeinpour, FL; Muccio, DD; Smith, CD; Vines, KK; Xia, G | 1 |
| Atigadda, VR; Boerma, LJ; Brouillette, WJ; Desphande, A; Grubbs, CJ; Lobo-Ruppert, S; Muccio, DD; Smith, CD; Xia, G | 1 |
| Atigadda, VR; Bland, KI; Brouillette, WJ; Deshpande, A; Grubbs, CJ; Kedishvili, N; Krontiras, H; Muccio, DD; Smith, CD; Wu, L; Xia, G | 1 |
| Athar, M; Atigadda, VR; Belyaeva, OV; Chang, PL; Chattopadhyay, D; Chou, CF; Elmets, CA; Grubbs, CJ; Kashyap, MP; Kedishvili, NY; Melo, N; Muccio, DD; Renfrow, MB; Sinha, R; Yang, Z | 1 |
Other Studies
5 other study(ies) available for bexarotene and uab 30
| Article | Year |
|---|---|
Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
Topics: Alitretinoin; Amino Acid Sequence; Bexarotene; Binding Sites; Crystallography, X-Ray; Fatty Acids, Unsaturated; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Naphthalenes; Nuclear Receptor Coactivator 2; Protein Binding; Protein Conformation; Protein Multimerization; Protein Structure, Secondary; Protein Structure, Tertiary; Retinoid X Receptor alpha; Tetrahydronaphthalenes; Tretinoin | 2014 |
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.
Topics: Humans; Kruppel-Like Factor 4; Ligands; Molecular Conformation; Neoplasms; Retinoid X Receptors; Retinoids | 2014 |
Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Bexarotene; Binding Sites; Cell Line; Cell Proliferation; Cell Transformation, Neoplastic; Crystallography, X-Ray; Fatty Acids, Unsaturated; Female; Humans; Hyperlipidemias; Mammary Neoplasms, Experimental; Models, Molecular; Molecular Structure; Naphthalenes; Rats; Retinoid X Receptor alpha; Stereoisomerism; Structure-Activity Relationship; Tetrahydronaphthalenes; Transcriptional Activation | 2014 |
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.
Topics: Animals; Anticarcinogenic Agents; Binding Sites; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Dyslipidemias; Fatty Acids, Unsaturated; Female; Humans; Mammary Neoplasms, Experimental; Molecular Conformation; Naphthalenes; Rats, Sprague-Dawley; Retinoid X Receptor alpha; Structure-Activity Relationship; Tamoxifen; Triglycerides | 2015 |
Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.
Topics: Humans; Inflammation; Ligands; Retinoid X Receptors; Skin Neoplasms; Tetrahydronaphthalenes; Tretinoin; Triglycerides | 2022 |